The inability of CCK to block (or CCK antagonists to substitute for) the stimulus effects of chlordiazepoxide

Pharmacology, Biochemistry, and Behavior
M A FoxA L Riley

Abstract

To further examine the relationship between cholecystokinin (CCK) and GABA, the present study assessed the ability of the CCK-A antagonist devazepide and the CCK-B antagonist L-365,260 to substitute for the stimulus effects of chlordiazepoxide (CDP), as well as the ability of CCK-8s to block these effects, in female Long-Evans rats within the conditioned taste aversion baseline of drug discrimination learning. Both devazepide and L-365,260 failed to substitute for the discriminative stimulus properties of CDP, and CCK-8s failed to block its stimulus effects. The benzodiazepine diazepam did substitute for, and the benzodiazepine antagonist flumazenil did block, the stimulus effects of CDP. This suggests that the lack of substitution for, or antagonism of, CDP by the CCK antagonists and CCK-8s, respectively, was not due to the inability of the present design to assess such effects. Possible bases for the current findings, e.g., necessity of an anxiogenic baseline, drug and receptor specificity, as well as the dose-response nature of the interaction, were discussed. Given that a relationship between CCK and GABA has been reported in other designs, the present results suggest that such a relationship may be preparation specific.

References

Jul 1, 1992·Pharmacology, Biochemistry, and Behavior·A Van HestB Olivier
Jan 1, 1992·Pharmacology, Biochemistry, and Behavior·G W StevensonA L Riley
Aug 1, 1991·Pharmacology, Biochemistry, and Behavior·F Woudenberg, T H Hijzen
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·L SinghG N Woodruff
Feb 14, 1991·European Journal of Pharmacology·J Harro, E Vasar
Jul 1, 1990·Trends in Pharmacological Sciences·S Ravard, C T Dourish
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S H HendryP C Emson
Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·M DerrienC Durieux
Dec 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·H J van MegenH G Westenberg
May 1, 1994·Pharmacology, Biochemistry, and Behavior·P M Melton, A L Riley
Sep 1, 1993·Pharmacology, Biochemistry, and Behavior·P M Melton, A L Riley
Jun 1, 1993·Trends in Pharmacological Sciences·J HarroJ Bradwejn
Feb 1, 1993·Pharmacology, Biochemistry, and Behavior·P M MeltonA L Riley
Apr 15, 1993·European Journal of Pharmacology·M RattrayS E File
Jan 1, 1996·Fundamental & Clinical Pharmacology·M BourinJ Bradwejn
Nov 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H J van MegenR S Kahn
Nov 18, 1998·Alcohol·P J KulkoskyB J Mattson
Jan 14, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D FeifelS Robeck
Apr 20, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M RezayatM R Zarrindast
Jan 1, 1992·Journal of Psychopharmacology·J BradwejnF Ervin

Related Concepts

L 365260
Metazoa
Benzodiazepinones
Librium
CCK-33
Cues
Discrimination (Process of Differentiation)
Discrimination Learning
Romazicon
Generalization (Psychology)

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, but also fevers and skin rashes. Here is the latest on this disease.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.